Blackstone explores sale of Anthos Therapeutics -sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Goldman Sachs Positive on The Blackstone Group (BX) Following Conference
December 6, 2023 2:09 PM ESTGoldman Sachs analyst Alexander Blostein reiterated a Buy rating and $115.00 price target on The Blackstone Group (NYSE: BX)
The analyst comments "Presenters: BX's President and COO Jonathan Gray presented at the GS 2023 US Financial Services Conference this afternoon (December 6). Bottom line:... More
